Hypertension 2024 Scientific Sessions  /  03. New Drugs in the Treatment of Hypertension  /  The Potential Role of Aldosterone Synthase Inhibition to More Effectively Treat Hypertension
Logo

American Heart Association

  53
  0

Final ID:

The Potential Role of Aldosterone Synthase Inhibition to More Effectively Treat Hypertension

  • Laffin, Luke  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
    • Author Disclosures:
    Luke Laffin: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Idorsia:Past (completed) ; Advisor:Gordy Health:Past (completed) ; Advisor:LucidAct Health:Past (completed) ; Research Funding (PI or named investigator):Astrazeneca:Past (completed) ; Consultant:Veradermics:Active (exists now) ; Consultant:Crispr Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Mineralys Therapeutics:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Recor:Active (exists now)
Meeting Info:

Hypertension 2024 Scientific Sessions

2024

Chicago, Illinois

Session Info:

03. New Drugs in the Treatment of Hypertension

Thursday, 09/05/2024 , 10:30AM - 12:00PM

Recent Advances Plenary

More abstracts on this topic:
Mechanisms of Endothelin, ETA and ETB Receptors in Hypertension

Pollock David

Endothelin Antagonists for Hypertension: Has Their Time Finally Arrived?

Schiffrin Ernesto

You have to be authorized to contact abstract author. Please, Login
Not Available